Carregant...
Atorvastatin inhibits the immediate-early response gene EGR1 and improves the functional pro of CD4(+)T-lymphocytes in acute coronary syndromes
Background- Adaptive immune-response is associated with a worse outcome in acute coronary syndromes. Statins have anti-inflammatory activity beyond lowering lipid levels. We investigated the effects of ex-vivo and in-vivo atorvastatin treatment in acute coronary syndromes on CD4(+)T-cells, and the u...
Guardat en:
| Publicat a: | Oncotarget |
|---|---|
| Autors principals: | , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Impact Journals LLC
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5392205/ https://ncbi.nlm.nih.gov/pubmed/28407684 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.15420 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|